What's in Azienda Sanitaria Locale 3, Torino's pipeline?

Azienda Sanitaria Locale 3, Torino has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Azienda Sanitaria Locale 3, Torino's portfolio?

Top competitors by shared drug class: Brigham and Women's Hospital, The George Institute.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/azienda-sanitaria-locale-3-torino.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Azienda Sanitaria Locale 3, Torino — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Azienda Sanitaria Locale 3, Torino pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Colchicine (for 6 months)	Colchicine (for 6 months)	phase 3	Microtubule inhibitor / Anti-inflammatory agent	Tubulin (alpha and beta subunits)	Immunology / Cardiovascular / Rheumatology
Colchicine (for 1 month)	Colchicine (for 1 month)	phase 3	Microtubule inhibitor / Anti-inflammatory agent	β-tubulin	Immunology / Rheumatology / Cardiovascular
Colchicine (for 3 months)	Colchicine (for 3 months)	phase 3	Microtubule inhibitor / Anti-inflammatory agent	β-tubulin	Rheumatology / Immunology

Therapeutic area mix

Immunology / Cardiovascular / Rheumatology · 1
Immunology / Rheumatology / Cardiovascular · 1
Rheumatology / Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Brigham and Women's Hospital · 1 shared drug class
The George Institute · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Azienda Sanitaria Locale 3, Torino:

Cite this brief

Drug Landscape (2026). Azienda Sanitaria Locale 3, Torino — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/azienda-sanitaria-locale-3-torino. Accessed 2026-05-17.